Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season.
Sara Y Tartof, Negar Aliabadi, Gabriella Goodwin, Jeff Slezak, Vennis Hong, Bradley Ackerson, Qing Liu, Sally Shaw, Sabrina Welsh, Banshri Kapadia, Brigitte C Spence, Joseph A Lewnard, Gregg S Davis, Michael Aragones, Michael Dutro
Published: 202510.1093/cid/ciaf496
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is an important cause of severe respiratory illness among older adults. Previously, we showed that the RSVpreF vaccine (Abrysvo; Pfizer) prevents RSV-related lower respiratory tract disease-related emerge…
Preview only. Read the full abstract at the source